Hourly Kinetics of Critical Organ Dysfunction in Extremely Preterm Infants

Orlyn C Lavilla1, Khyzer B Aziz2, Allison C Lure1

  • 1Department of Pediatrics and.

Insights

The neonatal sequential organ failure assessment score effectively predicts survival in extremely preterm infants from birth. This score shows a strong association with adverse outcomes, aiding in clinical care and research for high-risk neonates.

Area of Science:

  • Neonatalogy
  • Critical Care Medicine
  • Pediatric Research

Background:

  • Severity of illness scores are widely used in adult and pediatric ICUs but less so in neonatal ICUs.
  • Extremely premature infants (<29 weeks' gestation) with extremely low birth weight (<1,000 g) face high mortality and severe health complications.
  • Understanding organ dysfunction changes is crucial for managing these vulnerable infants.

Purpose of the Study:

  • To precisely measure organ dysfunction changes from birth to discharge/death in extremely preterm infants.
  • To evaluate the neonatal sequential organ failure assessment (neofSOFA) score's utility in differentiating outcomes.
  • To assess neofSOFA score performance based on gestational age and time from birth.

Main Methods:

  • Retrospective observational cohort study of 436 extremely preterm, extremely low birth weight infants (2012-2020).
  • Hourly calculation of neofSOFA scores from admission until death or discharge.
  • Analysis of score changes over time and correlation with clinical outcomes.

Main Results:

  • Longitudinal neofSOFA scores accurately discriminated between infants who died and those who survived.
  • The maximum neofSOFA score demonstrated excellent mortality prediction (AUC 0.91).
  • Patient-level variation was the primary driver of score changes; weekly average scores correlated with adverse outcomes.

Conclusions:

  • The neofSOFA score can predict survival versus nonsurvival as early as the first day of life.
  • The neofSOFA score is a valuable tool for assessing organ dysfunction and predicting outcomes in extremely preterm infants.
  • Score variation is largely patient-specific, highlighting individual responses to critical illness.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
38
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Factors Affecting Drug Distribution: Organ Perfusion Rate01:15

Factors Affecting Drug Distribution: Organ Perfusion Rate

Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
Perfusion rate-limited distribution relies on the...
358
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
22